Minor
CRESCENDO · Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL
Enrollment closed, study ongoing
Also in this update: Trial sites reduced: 69 → 58 locations
Acrotech Biopharma Inc.Phase 3 NCT06072131 Registry history of NCT06072131 on ClinicalTrials.gov (opens the registry)